Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,038 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $593.00 | 26 | $0 (2024) |
| Novo Nordisk Inc | $559.47 | 21 | $0 (2024) |
| Amgen Inc. | $490.15 | 10 | $0 (2024) |
| GlaxoSmithKline, LLC. | $259.41 | 12 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $228.22 | 3 | $0 (2023) |
| PFIZER INC. | $156.44 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $121.55 | 7 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $115.35 | 5 | $0 (2024) |
| Intersect ENT, Inc. | $114.74 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $87.28 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,393 | 59 | Amgen Inc. ($350.59) |
| 2023 | $1,404 | 55 | ABBVIE INC. ($339.35) |
| 2022 | $53.94 | 2 | Intersect ENT, Inc. ($34.79) |
| 2021 | $187.29 | 3 | Janssen Pharmaceuticals, Inc ($107.34) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: Cardiovascular | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: DIABETES | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.55 | General |
| Category: Cardiovascular | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 07/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $94.05 | General |
| 06/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: VACCINES | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.57 | General |
| Category: Cardiovascular | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: DIABETES | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: Inflammation | ||||||
| 06/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 87 | 184 | $31,673 | $11,406 |
| 2022 | 1 | 16 | 16 | $7,368 | $2,111 |
| 2021 | 4 | 225 | 280 | $56,598 | $17,243 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 41 | 94 | $21,587 | $8,015 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 42 | $6,897 | $2,497 | 36.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 22 | 48 | $3,188 | $893.92 | 28.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $7,368 | $2,111 | 28.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 72 | 95 | $21,375 | $8,076 | 37.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2021 | 90 | 111 | $20,601 | $3,397 | 16.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 45 | 52 | $7,956 | $3,092 | 38.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 22 | $6,666 | $2,678 | 40.2% |
About Jaime Fernandez, NP
Jaime Fernandez, NP is a Family healthcare provider based in Binghamton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2016. The National Provider Identifier (NPI) number assigned to this provider is 1487103024.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jaime Fernandez, NP has received a total of $3,038 in payments from pharmaceutical and medical device companies, with $1,393 received in 2024. These payments were reported across 119 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,038).
As a Medicare-enrolled provider, Fernandez has provided services to 328 Medicare beneficiaries, totaling 480 services with total Medicare billing of $30,759. Data is available for 3 years (2021–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Binghamton, NY
- Active Since 09/23/2016
- Last Updated 01/30/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1487103024
Products in Payments
- QULIPTA (Drug) $252.11
- Repatha (Biological) $236.52
- Otezla (Drug) $231.80
- XARELTO (Drug) $228.22
- VRAYLAR (Drug) $222.63
- Rybelsus (Drug) $190.65
- TRELEGY ELLIPTA (Drug) $144.10
- Ozempic (Drug) $140.59
- JARDIANCE (Drug) $137.61
- ELIQUIS (Drug) $124.32
- UBRELVY (Drug) $118.26
- LEQVIO (Drug) $115.35
- BREZTRI (Drug) $107.52
- VOQUEZNA (Drug) $84.33
- SINUVA (Drug) $79.95
- PREVNAR 20 (Biological) $72.24
- Cologuard Collection Kit (Device) $70.83
- PROPEL (Device) $34.79
- CLEVIPREX (Drug) $23.30
- CAMZYOS (Drug) $22.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Binghamton
Ryan Little, Np, NP
Family — Payments: $12,861
Miss. Victoria Engler, Fnp, FNP
Family — Payments: $7,379
Kristen Tarbox, Np, NP
Family — Payments: $3,278
Allison Hawk, Np, NP
Family — Payments: $3,042
Mary Chesna, Np, NP
Family — Payments: $2,857
Holli Stayton, Fnp, FNP
Family — Payments: $1,862